These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 24566391

  • 1. Role of plaque calcification regulators osteoprotegerin and matrix Gla-proteins in stable angina and acute myocardial infarction.
    Margonato A, Gorla R, Macchi A, Buzzetti F, Franzoni I, Pedrigi MC, Rosa I, Sirtori M, Villa I, Rubinacci A.
    J Cardiovasc Med (Hagerstown); 2015 Mar; 16(3):156-62. PubMed ID: 24566391
    [Abstract] [Full Text] [Related]

  • 2. Circulating osteogenic proteins are associated with coronary artery calcification and increase after myocardial infarction.
    Pesaro AE, Katz M, Liberman M, Pereira C, Mangueira CLP, de Carvalho AEZ, Carvalho KS, Nomura CH, Franken M, Serrano CV.
    PLoS One; 2018 Mar; 13(8):e0202738. PubMed ID: 30138356
    [Abstract] [Full Text] [Related]

  • 3. The relation between the levels of osteoprotegerin and the degree of coronary artery disease in patients with acute coronary syndrome and stable angina pectoris.
    Aksu F, Ozçelik F, Kunduracilar H, Barutçu A, Yel M, Umit EG, Altun A.
    Kardiol Pol; 2014 Mar; 72(1):34-41. PubMed ID: 24469748
    [Abstract] [Full Text] [Related]

  • 4. Serum levels of calcification inhibition proteins and coronary artery calcium score: comparison between transplantation and dialysis.
    Mazzaferro S, Pasquali M, Pugliese F, Barresi G, Carbone I, Francone M, Sardella D, Taggi F.
    Am J Nephrol; 2007 Mar; 27(1):75-83. PubMed ID: 17259697
    [Abstract] [Full Text] [Related]

  • 5. Can osteoprotegerin be used to identify the presence and severity of coronary artery disease in different clinical settings?
    Hosbond SE, Diederichsen AC, Saaby L, Rasmussen LM, Lambrechtsen J, Munkholm H, Sand NP, Gerke O, Poulsen TS, Mickley H.
    Atherosclerosis; 2014 Oct; 236(2):230-6. PubMed ID: 25104079
    [Abstract] [Full Text] [Related]

  • 6. Serum levels of osteoprotegerin and RANKL in patients with ST elevation acute myocardial infarction.
    Crisafulli A, Micari A, Altavilla D, Saporito F, Sardella A, Passaniti M, Raffa S, D'anneo G, Lucà F, Mioni C, Arrigo F, Squadrito F.
    Clin Sci (Lond); 2005 Oct; 109(4):389-95. PubMed ID: 15926884
    [Abstract] [Full Text] [Related]

  • 7. Predictive Value of Osteoprotegerin for Detecting Coronary Artery Calcification in Type 2 Diabetes Mellitus Patients in Correlation with Extent of Calcification Detected by Multidetector Computed Tomography.
    Ahmed S, Sobh R.
    Endocr Metab Immune Disord Drug Targets; 2019 Oct; 19(6):845-851. PubMed ID: 30747085
    [Abstract] [Full Text] [Related]

  • 8. Matrix Gla protein is associated with coronary artery calcification as assessed by electron-beam computed tomography.
    Jono S, Ikari Y, Vermeer C, Dissel P, Hasegawa K, Shioi A, Taniwaki H, Kizu A, Nishizawa Y, Saito S.
    Thromb Haemost; 2004 Apr; 91(4):790-4. PubMed ID: 15045141
    [Abstract] [Full Text] [Related]

  • 9. Bone metabolism regulators and arterial stiffness in postmenopausal women.
    Albu A, Fodor D, Bondor C, Crăciun AM.
    Maturitas; 2013 Oct; 76(2):146-50. PubMed ID: 23916080
    [Abstract] [Full Text] [Related]

  • 10. The value of serum osteoprotegerin levels in patients with angina like chest pain undergoing diagnostic coronary angiography.
    Ghaffari S, Yaghoubi A, Baghernejad R, Sepehrvand N, Sokhanvar S, Haghjou AG.
    Cardiol J; 2013 Oct; 20(3):261-7. PubMed ID: 23788300
    [Abstract] [Full Text] [Related]

  • 11. Osteoprotegerin and B-type natriuretic peptide in acute coronary syndromes with preserved systolic function: relation to coronary artery disease extension.
    Palazzuoli A, Ascione R, Gallotta M, Calabrò A, Gonnelli S, Quatrini I, Campagna MS, Franci B, Nuti R.
    Int J Cardiol; 2009 Nov 12; 137(3):295-8. PubMed ID: 18707771
    [Abstract] [Full Text] [Related]

  • 12. Osteoprotegerin and B-type natriuretic peptide in non-ST elevation acute coronary syndromes: relation to coronary artery narrowing and plaques number.
    Palazzuoli A, Rizzello V, Calabrò A, Gallotta M, Martini G, Quatrini I, Campagna MS, Franci B, Nuti R.
    Clin Chim Acta; 2008 May 12; 391(1-2):74-9. PubMed ID: 18328262
    [Abstract] [Full Text] [Related]

  • 13. [Calcified coronary artery disease and serum markers].
    Mori K, Jono S.
    Clin Calcium; 2007 Mar 12; 17(3):340-5. PubMed ID: 17339737
    [Abstract] [Full Text] [Related]

  • 14. Monocyte heterogeneity in myocardial infarction with and without ST elevation and its association with angiographic findings.
    Arslan U, Kocaoğlu I, Balci MM, Gülkan B, Falay MY, Temizhan A.
    Coron Artery Dis; 2013 Aug 12; 24(5):404-11. PubMed ID: 23612365
    [Abstract] [Full Text] [Related]

  • 15. Osteoprotegerin in ST-elevation myocardial infarction: prognostic impact and association with markers of myocardial damage by magnetic resonance imaging.
    Fuernau G, Zaehringer S, Eitel I, de Waha S, Droppa M, Desch S, Schuler G, Adams V, Thiele H.
    Int J Cardiol; 2013 Sep 01; 167(5):2134-9. PubMed ID: 22704876
    [Abstract] [Full Text] [Related]

  • 16. [Clinical implication and association between local and systemic levels of interleukin-1β and interleukin-10 in patients with coronary artery disease].
    Yan HB, Li WZ, Zhao HJ, Song L, Zheng B, Zhou P, Liu C.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Feb 01; 39(2):142-6. PubMed ID: 21426749
    [Abstract] [Full Text] [Related]

  • 17. The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis.
    Shroff RC, Shah V, Hiorns MP, Schoppet M, Hofbauer LC, Hawa G, Schurgers LJ, Singhal A, Merryweather I, Brogan P, Shanahan C, Deanfield J, Rees L.
    Nephrol Dial Transplant; 2008 Oct 01; 23(10):3263-71. PubMed ID: 18463323
    [Abstract] [Full Text] [Related]

  • 18. In-hospital free fatty acids levels predict the severity of myocardial ischemia of acute coronary syndrome.
    Ma P, Han L, Lv Z, Chen W, Hu H, Tu J, Zhou X, Liu SM.
    BMC Cardiovasc Disord; 2016 Feb 01; 16():29. PubMed ID: 26830193
    [Abstract] [Full Text] [Related]

  • 19. Serum pentraxin 3 levels are associated with the complexity and severity of coronary artery disease in patients with stable angina pectoris.
    Karakas MF, Buyukkaya E, Kurt M, Motor S, Akcay AB, Buyukkaya S, Karakas E, Bilen P, Sen N.
    J Investig Med; 2013 Feb 01; 61(2):278-85. PubMed ID: 23237880
    [Abstract] [Full Text] [Related]

  • 20. Possible role of osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand as markers of plaque instability in coronary artery disease.
    Shaker OG, El-Shehaby A, Nabih M.
    Angiology; 2010 Nov 01; 61(8):756-62. PubMed ID: 20498140
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.